Pcv19 - Patterns of Anticoagulation Control and Clinical Outcomes in Atrial Fibrillation Patients Treated With Vitamin K Antagonists: A Real-World Study Using Population-Based Data and Group-Based Trajectory Models

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.566
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Quality of INR Control and Switching to Non-Vitamin K Oral Anticoagulants Between Women and Men With Atrial Fibrillation Treated With Vitamin K Antagonists in Spain. A Population-Based, Real-World Study

PLoS ONE
Multidisciplinary
2019English

Pcv115 - Quality of Inr Control and Switching to Doac Between Women and Men With Atrial Fibrillation Treated With Vitamin K Antagonists in Spain. A Population-Based, Real-World Study.

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Long-Term Vitamin K Antagonists Treatment Patterns of Non-Valvular Atrial Fibrillation (NVAF): A Population-Based Cohort Study

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2016English

Patient Characteristics and Bleeding Events in Nonvalvular Atrial Fibrillation Patients Treated With Apixaban or Vitamin K Antagonists: Real-World Evidence From Italian Administrative Databases

Journal of Comparative Effectiveness Research
Health Policy
2018English

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

JAMA Cardiology
Cardiovascular MedicineCardiology
2016English

Clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Exposure to Vitamin K Antagonists and Kidney Function Decline in Patients With Atrial Fibrillation and Chronic Kidney Disease

Research and Practice in Thrombosis and Haemostasis
2019English

Pcv79 - Real-World Cost-Effectiveness of Rivaroxaban Compared With Vitamin K Antagonists in the Context of Stroke Prevention in Atrial Fibrillation in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy